Mark L. Pacala, a director at Oncology Institute, Inc. ($TOI), made one open market purchase of shares in the last year, totaling $94,338, with the most recent on March 26, 2025. This ranks 2,450th among 4,983 insiders, well below the $1.5 million average. He sold shares three times for $200,000 total, most recently on November 18, 2025, ranking 8,416th out of 11,678 insiders versus their $8.6 million average.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 20, 2025 | Oncology Institute, Inc. | $TOI | Pacala Mark L | Director | A | Common Stock | 35494 | $0.00 | 256,761.0000 | 99,303,511 | 16.04% | 0.04% |
| Nov. 20, 2025 | Oncology Institute, Inc. | $TOI | Pacala Mark L | Director | A | Common Stock | 46296 | $0.00 | 221,267.0000 | 99,303,511 | 26.46% | 0.05% |
| Nov. 18, 2025 | Oncology Institute, Inc. | $TOI | Pacala Mark L | Director | S | Common Stock | 2160 | $4.00 | 222,811.0000 | 99,303,511 | 0.96% | 0.00% |
| Nov. 18, 2025 | Oncology Institute, Inc. | $TOI | Pacala Mark L | Director | S | Common Stock | 1210 | $4.00 | 221,601.0000 | 99,303,511 | 0.54% | 0.00% |
| Nov. 18, 2025 | Oncology Institute, Inc. | $TOI | Pacala Mark L | Director | S | Common Stock | 46630 | $4.00 | 174,971.0000 | 99,303,511 | 21.04% | 0.05% |
| March 26, 2025 | Oncology Institute, Inc. | $TOI | Pacala Mark L | Director | P | Common Stock | 90562 | $1.04 | 224,971.0000 | 77,470,886 | 67.38% | 0.12% |
| March 26, 2025 | Oncology Institute, Inc. | $TOI | Pacala Mark L | Director | P | Common Warrant | 42281 | $0.13 | 42,281.0000 | 77,470,886 | 9999.99% | 0.05% |
| Nov. 22, 2024 | Oncology Institute, Inc. | $TOI | Pacala Mark L | Director | A | Common stock | 50000 | $0.00 | 134,409.0000 | 77,292,849 | 59.24% | 0.06% |
| Nov. 12, 2024 | Oncology Institute, Inc. | $TOI | Pacala Mark L | Director | J | Common stock | 30372 | $0.00 | 84,409.0000 | 77,292,849 | 26.46% | 0.04% |
| Nov. 12, 2024 | Oncology Institute, Inc. | $TOI | Pacala Mark L | Director | J | Common stock | 20248 | $0.00 | 114,781.0000 | 77,292,849 | 15.00% | 0.03% |
| Dec. 26, 2023 | Oncology Institute, Inc. | $TOI | Pacala Mark L | Director | A | Common stock | 46630 | $0.00 | 135,029.0000 | 73,265,621 | 52.75% | 0.06% |
| March 17, 2023 | Oncology Institute, Inc. | $TOI | Pacala Mark L | Director | A | Common stock | 6562 | $0.00 | 88,399.0000 | 73,265,621 | 8.02% | 0.01% |